How should I manage an adult with acute colonic pseudo‑obstruction (Ogilvie’s syndrome) presenting with abdominal distension, pain, nausea and absent bowel movements?

Management of Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome)

For an adult presenting with acute colonic pseudo-obstruction, immediately initiate conservative management with bowel rest, nasogastric decompression, aggressive IV fluid resuscitation, electrolyte correction, and discontinuation of all opioids and anticholinergic medications—if the cecal diameter reaches ≥12 cm or symptoms persist beyond 48-72 hours without improvement, administer neostigmine 2 mg IV over 3-5 minutes with continuous cardiac monitoring. 1, 2, 3, 4

Initial Assessment and Risk Stratification

Confirm the Diagnosis

• Obtain CT abdomen/pelvis with IV contrast to exclude mechanical obstruction (malignancy, volvulus, stricture) and assess for complications including bowel ischemia, perforation, or pneumatosis intestinalis 1, 3, 4
• Plain abdominal radiographs show massive colonic dilatation without a transition point, but CT is superior for detecting complications and has approximately 90% diagnostic accuracy 5, 3
• Measure the cecal diameter on imaging—diameters ≥12 cm carry significantly increased perforation risk and mandate more aggressive intervention 3, 4, 6

Identify Life-Threatening Complications Requiring Emergency Surgery

• Peritoneal signs (guarding, rebound tenderness, rigidity) indicate perforation or ischemia and require immediate surgical consultation 1, 5, 3
• CT findings of ischemia: abnormal bowel wall enhancement, pneumatosis intestinalis, portal venous gas, or free intraperitoneal air mandate emergency laparotomy 1, 5, 3
• Hemodynamic instability with hypotension, tachycardia, fever, and elevated lactate suggests septic shock from perforation—these patients need urgent operative intervention 5, 7, 3
• Mortality increases from 15% with intact bowel to 40-50% after perforation, making early detection of complications critical 3, 4, 6

Conservative Management (First-Line for All Patients Without Complications)

Bowel Decompression

• Nasogastric tube placement removes proximal gastrointestinal contents and reduces further colonic distension 1, 2, 3
• Rectal tube insertion provides distal decompression and should be placed in all patients 1, 2, 6
• Maintain strict NPO status (nothing by mouth) until colonic distension resolves 2, 3, 4

Aggressive Supportive Care

• IV fluid resuscitation with isotonic crystalloids to correct the profound hypovolemia from third-spacing into the dilated colon 1, 7, 2
• Electrolyte correction is mandatory—particularly potassium, magnesium, and phosphate, as hypokalemia and hypomagnesemia directly impair colonic motility 1, 2, 3
• Patient mobilization: ambulate the patient or reposition every 2 hours if bedridden, as immobility is a major contributing factor 2, 3, 4

Eliminate Precipitating Factors

• Discontinue all opioid analgesics immediately—opioids are the most common iatrogenic cause of colonic pseudo-obstruction and directly inhibit colonic motility 1, 2, 3
• Stop anticholinergic medications (antihistamines, tricyclic antidepressants, antipsychotics) as they worsen colonic atony 2, 3, 4
• Avoid calcium channel blockers and other medications that impair intestinal motility 2, 3
• Treat underlying medical conditions (sepsis, metabolic derangements, cardiac or respiratory failure) that contribute to autonomic dysfunction 2, 3, 4

Monitoring During Conservative Management

• Serial abdominal examinations every 4-6 hours to detect peritoneal signs 3, 4, 6
• Daily plain abdominal radiographs to measure cecal diameter and assess for progression 3, 4, 6
• Monitor for clinical deterioration: worsening abdominal pain, fever, leukocytosis, or rising lactate 3, 4, 6
• Conservative management succeeds in approximately 40-50% of patients within 48-72 hours 3, 4, 6

Pharmacologic Decompression with Neostigmine (Second-Line)

Indications for Neostigmine

• Failure of conservative management after 48-72 hours without reduction in colonic distension 1, 2, 3
• Cecal diameter ≥12 cm at presentation, even if duration is <48 hours, due to high perforation risk 3, 4, 6
• Symptomatic patients with severe abdominal distension and pain despite conservative measures 2, 3, 4

Neostigmine Administration Protocol

• Dose: 2 mg IV administered slowly over 3-5 minutes 1, 2, 3
• Continuous cardiac monitoring is mandatory during and for at least 30 minutes after administration due to risk of bradycardia and heart block 2, 3, 4
• Have atropine 0.5-1 mg IV immediately available at bedside to reverse cholinergic side effects 2, 3, 4
• Response typically occurs within 10-30 minutes with passage of flatus and stool, accompanied by rapid clinical improvement 2, 3, 4
• Neostigmine achieves successful decompression in approximately 75-90% of patients 3, 4, 6

Contraindications to Neostigmine

• Active bronchospasm or severe asthma (neostigmine causes bronchoconstriction) 2, 3, 4
• Bradycardia, heart block, or recent myocardial infarction 2, 3, 4
• Mechanical bowel obstruction (must be excluded by imaging first) 2, 3, 4
• Suspected bowel perforation or peritonitis 3, 4
• Renal failure with creatinine clearance <30 mL/min (relative contraindication) 3, 4

Management of Neostigmine Non-Responders

• If no response within 30-60 minutes, a second dose of neostigmine 2 mg IV may be administered 3, 4
• Patients who fail two doses of neostigmine require colonoscopic decompression 3, 4, 6

Colonoscopic Decompression (Third-Line)

Indications

• Neostigmine failure after two doses without adequate decompression 1, 2, 3
• Neostigmine contraindications in patients requiring urgent decompression 2, 3, 4
• Recurrent pseudo-obstruction after initial successful neostigmine treatment 3, 4, 6

Colonoscopic Technique

• Perform with minimal air insufflation (use CO2 if available) to avoid worsening distension 3, 4
• Advance to the cecum or hepatic flexure and aspirate luminal gas 3, 4
• Consider placement of a decompression tube through the colonoscope to maintain decompression, though evidence for benefit is mixed 3, 4, 6
• Success rate is 70-80% for initial decompression, but recurrence occurs in 40-50% of patients 3, 4, 6

Risks of Colonoscopy in ACPO

• Perforation risk is 1-3%, higher than diagnostic colonoscopy due to thin, distended colonic wall 3, 4, 6
• Avoid excessive air insufflation and aggressive manipulation 3, 4

Surgical Intervention (Last Resort)

Indications for Surgery

• Perforation documented on imaging or suspected based on peritoneal signs 3, 4, 6
• Bowel ischemia with CT evidence of pneumatosis, portal venous gas, or abnormal wall enhancement 3, 4, 6
• Failure of all medical and endoscopic therapies with persistent massive distension and clinical deterioration 3, 4, 6

Surgical Options

• Tube cecostomy: minimally invasive option for decompression in high-risk surgical candidates 3, 4, 6
• Segmental colectomy: for localized ischemia or perforation 3, 4, 6
• Subtotal colectomy with end ileostomy: for diffuse colonic ischemia or perforation 3, 4, 6
• Surgical mortality ranges from 30-50%, reflecting the severity of underlying illness and complications 3, 4, 6

Common Pitfalls and How to Avoid Them

• Delaying neostigmine in high-risk patients: Do not wait 72 hours if the cecal diameter is ≥12 cm—administer neostigmine within 24-48 hours to prevent perforation 3, 4, 6
• Continuing opioids for pain control: Opioids directly cause and perpetuate colonic pseudo-obstruction; use non-opioid analgesics (acetaminophen, NSAIDs if not contraindicated) instead 1, 2, 3
• Missing mechanical obstruction: Always obtain CT imaging before neostigmine—administering neostigmine in true mechanical obstruction can cause perforation 2, 3, 4
• Underestimating perforation risk: Patients may have minimal peritoneal signs despite perforation due to immunosuppression or altered mental status; maintain high suspicion and obtain serial imaging if clinical deterioration occurs 3, 4, 6
• Inadequate monitoring during neostigmine: Bradycardia and cardiac arrest can occur—continuous telemetry and bedside atropine are non-negotiable 2, 3, 4

Recurrent or Refractory Cases

• Patients with recurrent ACPO despite successful initial treatment may have underlying chronic intestinal pseudo-obstruction or severe colonic dysmotility 3, 6
• Consider referral to a motility specialist for colonic manometry and evaluation for chronic intestinal pseudo-obstruction if episodes recur 1, 3
• Long-term management may require scheduled neostigmine, prokinetic agents, or ultimately surgical intervention (colectomy) in refractory cases 3, 6